Y.A.Z Initiatives: 79 Projects On Paper, but 2026 Is the Test of Equity, Project Finance, and Execution

Getting To Know The Company

The first thing to understand about Y.A.Z Initiatives is that this is not yet a mature earnings story. It is an urban-renewal platform, concentrated mainly in Tel Aviv, whose economics depend on a long chain: tenant signatures, planning approvals, permits, project finance, construction starts, sales, and only then surplus release. The company presentation shows 79 projects, NIS 5.75 billion of projected revenue, and NIS 1.663 billion of projected surplus. The market cap, by contrast, is around NIS 198 million. At first glance that looks like an extreme gap between market value and economic value. That is only a partial read.

What is working now is clear. The company does not have a pipeline problem. Of the 79 projects, 72 have already reached the required-signature threshold, it has no completed-and-unsold projects, and during 2025 it moved from an owner-loan and bridge-equity model to public equity and a listed bond. After the balance-sheet date, two concrete de-risking events also arrived for Shlomo HaMelech 89: a full building permit and a new project-finance agreement.

But the active bottleneck is not demand and it is not project count. The bottleneck is how much more equity, financing, and execution still have to be injected before the headline numbers in the presentation turn into real money. That already shows up in the 2025 filing: revenue was almost flat at NIS 49.1 million, gross profit fell to NIS 3.1 million from NIS 7.3 million, operating loss widened to NIS 8.6 million, cash flow from operations was negative NIS 67.6 million, and unrestricted cash at year-end was just NIS 4.9 million. The larger cash balance, NIS 81.5 million, sat in designated and restricted accounts.

That is also why the story matters now. In 2025 the company strengthened equity, issued bonds, improved access to funding, and showed that pledged projects such as Shlomo HaMelech 89 can still move forward after year-end. On the other hand, the filing also shows that part of the balance-sheet jump is accounting-driven, part of the projected surplus is already pledged to bondholders, and much of the pipeline still sits at a stage where permits and financing have to come before execution.

Four points a quick read can miss:

• The NIS 1.663 billion projected-surplus headline in the presentation includes NIS 619 million of equity the company still has to inject into projects. In the annual report's project-stage table, the same portfolio appears as NIS 1.044 billion of projected surplus.
• Only 25 projects are in construction or near permit. Another 29 are still at permit submission or near-submission stage, and 7 more remain in business development.
• There is no completed unsold inventory, which is positive, but there is also not much inventory already deep into execution. At year-end only 24 units in projects under construction remained unsigned.
• The sharp balance-sheet growth did not come only from more spending and faster execution. NIS 102.7 million was recognized for the first time as land value against an obligation to provide construction services, and the accounting-policy note says that under the old policy only NIS 41.0 million would have been recognized.

Events And Triggers

The first trigger: 2025 was the transition year into the capital markets. The company completed an equity raise that lifted share premium to NIS 130.4 million from NIS 77.6 million, and in December 2025 it issued Series A bonds with NIS 83 million of par value. That strengthens the funding layer, but it also changes how the company should be read: from now on the story is not only "there are projects," but also "what has already been pledged, what has already been released, and how much room is left above the debt."

The second trigger: bond-proceeds release was gradual, not automatic. On January 7, 2026, about NIS 76 million, roughly 92% of the offering proceeds, was released. Full release was delayed until the registration of the security over the surplus of Shlomo HaMelech 89. Only on February 19, 2026 were all conditions completed, with that project also pledged, and the full proceeds were transferred to the company. That matters, because it shows that the new financing flexibility came through pledged assets and execution milestones, not through unrestricted cash appearing in the bank account.

The third trigger: Shlomo HaMelech 89 moved after year-end from almost-ready to genuinely ready. At December 2025 it was still disclosed as a project nearing permit, with 10 units for sale, 5 units already sold, projected revenue of NIS 46.9 million, and projected surplus of NIS 7.45 million. On February 9, 2026, it received a full building permit, and on February 11, 2026, it signed a new financing agreement with Ayalon and Rubi. The framework includes up to NIS 15 million of cash credit, a buyer-guarantee line of up to NIS 47 million, other guarantees of about NIS 63 million, interest at prime plus 1.25%, and an equity requirement of about NIS 5.1 million alongside a pre-sales target. This is real de-risking, but it also reminds investors what is required just to move one project.

The fourth trigger: controlling-shareholder loans still stood at NIS 11.0 million in the books at year-end, due for final repayment by June 2026. After the balance-sheet date, on March 18, 2026, the company repaid the remaining balance of about NIS 11.6 million including interest. So early 2026 already looks cleaner than the December 31, 2025 balance sheet, but that clean-up came only after equity and debt funding, not out of operating cash generation.

Efficiency, Profitability, And Competition

The main takeaway from 2025 is that the company grew much faster in balance-sheet scale and headline numbers than in ongoing profitability. Revenue slipped only slightly to NIS 49.1 million from NIS 50.8 million, but gross profit dropped 57% to just NIS 3.1 million. Selling, marketing, and advertising expense rose to NIS 2.5 million, G&A rose to NIS 8.2 million, and operating loss widened to NIS 8.6 million. On top of that, finance expense jumped to NIS 5.7 million from NIS 0.8 million, driven by additional project-finance structures, shareholder loans, and a meaningful financing component inside the construction-services obligation.

Management explains the profitability erosion through three factors: the completion of the Klisher project early in the year, the start of construction at Miriam HaHashmona'it 32-34 and Matmon HaCohen 8 and 10 at still-low completion rates, and higher construction costs plus longer project duration. That explanation makes sense, but it also means 2025 is not yet benefiting from the new project stack the company is marketing, while the costs are already in the numbers.

What is more interesting is that the balance-sheet jump is not all operational economics. Inventory of buildings under construction and units for sale rose to NIS 208.7 million from NIS 85.5 million, and the company explains that the main reason was first-time recognition of land value at Miriam HaHashmona'it 32-34, Biltmore 8, and Biltmore 13, about NIS 102 million, against an obligation to provide construction services. In the accounting-policy note, the company adds that under the old policy only about NIS 41.0 million would have been recognized. So part of the jump in assets and liabilities is not the same as cash, sales, or freely accessible surplus.

From a competitive perspective, Y.A.Z is trying to sell investors on a combination of development and an in-house contractor layer. The company explicitly says that many urban-renewal agreements and financing discussions assume that Y.A.Z Bniya will be the execution contractor, and that there are only a limited number of unrestricted G5 contractors with meaningful urban-renewal experience. That is an advantage. But it is also a dependency. When the company itself says that replacing Y.A.Z Bniya could hurt its competitive advantages, even if not necessarily in a material way, it is effectively admitting that its moat is also a concentration point.

Cash Flow, Debt, And Capital Structure

Cash framing: all-in cash flexibility

For Y.A.Z, the right lens is all-in cash flexibility. It would be misleading to present this as normalized recurring cash generation, because the thesis is not about a mature operating business with stable maintenance capex. The thesis is about a developer that constantly has to inject equity, fund planning, satisfy finance conditions, and carry overhead until projects reach the stage where surplus can actually be released.

On that basis, 2025 was a tight year. Cash flow from operations was negative NIS 67.6 million. Even after excluding NIS 48.0 million invested in long-term land inventory for future projects, the operating burn still stands at negative NIS 19.6 million. Investing used another NIS 15.9 million, while financing added NIS 87.4 million. In plain terms, the company did not fund 2025 from the existing business. It funded 2025 from equity, debt, and shareholder-loan inflows.

At year-end the company had NIS 4.9 million of cash and cash equivalents, plus NIS 81.5 million of cash and deposits in designated and restricted accounts. That gap matters. Anyone looking only at the NIS 86.4 million headline cash-and-deposits number misses that the unrestricted portion is very small. The board did say there is no liquidity problem, pointing to positive working capital of NIS 91.2 million and positive 12-month working capital of NIS 58.6 million, but it also based that conclusion on a 24-month forecast that assumes credit availability, surplus release, and additional financing access.

The debt does not look stressed, but shareholder access is less clean

Series A bonds were carried at NIS 81.4 million at year-end. Principal is due 25%, 50%, and 25% between December 2028 and March 2030, and the fixed coupon is 7.97%. The financial covenants are not currently tight: minimum equity of NIS 50 million, minimum equity-to-assets ratio of 13%, and maximum net-obligation-to-pledged-assets ratio of 81%. At year-end 2025 the company was in compliance with all of them, and the actual equity-to-assets ratio was about 27.4%.

But the collateral layer also matters. The bond is backed by the surplus of seven projects: Miriam HaHashmona'it 32-34, Shlomo HaMelech 89, Zichron Yaakov 10, Bloch 11, Biltmore 8, Biltmore 13, and Harugei HaMalchut 14-16, plus the rights in the trust account. That means part of the future-surplus story the company presents is already sitting first behind creditor protection. This is not distress, but it is a real limit on how much of that value is actually accessible to shareholders.

The positive side is that the company already cleaned up some of the more expensive or less permanent layers after year-end. The controlling-shareholder loan was repaid in full in March 2026, and Shlomo HaMelech 89 moved to a fresh financing agreement. The less comfortable side is that the clean-up happened only after capital-market funding, not from internally released project cash.

Forward View

Before looking at 2026, four points need to stay front and center:

• The portfolio headline is still much bigger than the signed-contract layer. As of December 31, 2025, the company disclosed NIS 311.7 million of revenue yet to be recognized from binding sales contracts and NIS 313.2 million of expected collections from those same contracts, versus a portfolio headline of NIS 5.75 billion of projected revenue.
• The bottleneck is not finished inventory. There are no completed-and-unsold projects, and only 24 units in projects under construction remained unsigned. The bottleneck is moving more projects from planning into financed execution.
• The surplus-release schedule is still back-end loaded. In the presentation, the company shows for the 72 non-business-development projects NIS 15 million of release in 2026, NIS 32 million in 2027, NIS 206 million in 2028, NIS 386 million in 2029, NIS 344 million in 2030, and NIS 421 million from 2031 onward.
• The post-balance-sheet improvement is real, but still specific. Shlomo HaMelech 89 moved from nearing permit into actual permit and financing, but the Y.A.Z thesis only changes meaningfully if that transition repeats across several more projects.

In that sense, 2026 looks like a transition year into execution, but for the market it will also be a proof year. If the company starts showing more permits, more financing agreements, and more construction starts in projects that are already deep in the stack, then the 79-project portfolio can begin to be read as real value. If not, the big numbers will remain mainly presentation numbers.

Another layer the market is likely to test is the quality of the already-signed contract base. The signed revenue backlog for future years is meaningful, but it is not huge relative to the full portfolio. In 2026 the company expects to collect NIS 73.2 million from signed contracts while recognizing NIS 44.2 million of revenue from them. In 2027 the revenue yet to be recognized from signed contracts jumps to NIS 132.0 million, but expected collections from that layer fall to NIS 44.7 million. In other words, there is real signing and collection activity, but not yet a signed-contract cushion large enough to carry the full portfolio story by itself.

For the thesis to strengthen over the next 2 to 4 quarters, three things need to happen together. First, progress like Shlomo HaMelech 89 must stop being a one-off and start appearing in more projects. Second, the company has to show that finance expense and operating cash burn do not keep deteriorating as the portfolio grows. Third, the gap between the portfolio headline and the layer of unrestricted cash and signed contracts has to begin closing.

Risks

The first risk is construction cost and financing pressure. The company notes that the residential construction-input index rose about 5.1% in 2025, that tighter industry financing conditions can lengthen project-finance processes, and that a 1% rate increase would raise annual finance costs by about NIS 342 thousand. For a relatively small developer with limited unrestricted cash, that is not accounting noise. It directly affects timelines, profitability, and the ability to advance more projects in parallel.

The second risk is that the required-signature threshold is not the end of the story. The company itself says that eventual execution still requires full tenant consent, new plans when needed, permits, project finance, and actual evacuation of the property. So 72 projects with the required majority are not the same thing as 72 projects ready to build.

The third risk is quality of accessible value. The obligation to provide construction services stood at NIS 151.8 million at year-end, long-term land inventory at NIS 92.0 million, and the bond is backed by the surplus of seven projects. That means the accounting improvement in the asset side still sits against a heavy layer of liabilities, guarantees, and pledges. Anyone jumping directly from projected surplus to equity value is skipping several steps in the middle.

The fourth risk is execution concentration. The company benefits from having Y.A.Z Bniya next to it as an experienced unrestricted contractor. But the same point can become a weakness if there is delay, contractual friction, or a need to replace that contractor across a broad set of projects.

There is, however, one calming signal: short-interest data is negligible. In the latest weekly market snapshot there was no short position at all, while the sector average stood at 0.84% of float. That does not mean the market fully believes the story, but it does mean skepticism is not currently showing up as material short pressure.

Conclusions

Y.A.Z Initiatives looks very attractive if one looks only at project count, portfolio surplus, and market cap. But that is not the right way to read it. Right now, this is a company that has proven it can build a pipeline, reach the required signature thresholds, enter the capital markets, and advance pledged projects such as Shlomo HaMelech 89. It has not yet proven to the same degree that this pipeline converts at a fast enough pace into permits, financing, execution, profit, and cash flexibility.

Current thesis: Y.A.Z is a financing-and-execution story before it is an earnings story, and the large portfolio headlines will stay far from shareholders unless 2026 brings more projects into permit, financing, and construction-start stage.

What changed: 2025 and early 2026 moved the company into the public markets, cleaned up part of the shareholder-loan structure, and advanced Shlomo HaMelech 89 from near-permit into actual financing. But the same period also showed how dependent the balance sheet and the thesis still are on accounting recognition, capital raises, and future equity injections.

Counter-thesis: One could argue that the market is putting too much weight on year-end unrestricted cash and too little weight on the fact that public capital access is now in place, controlling-shareholder loans were cleaned up, and pledged projects are already moving, so the gap between market cap and portfolio value could start closing quickly after 2 or 3 more operating milestones of the same kind.

What could change the market reading: more permits, more financing agreements, and a clearer improvement in unrestricted cash or operating cash flow. On the other hand, further finance-expense growth without a matching step-up in execution would weigh on the story.

Why this matters: in a small urban-renewal developer, value is not measured by how many projects appear in a presentation. It is measured by how many of them are close enough to self-fund and generate surplus that can actually move up to common shareholders.

What has to happen now is not another pipeline slide. It is 2 to 4 quarters in which Y.A.Z proves that projects are genuinely moving to the next stage, that financing is not eating all the economics, and that the gap between accounting value and shareholder-accessible value is beginning to narrow.